ask="N/A"
ask_size="N/A"
average_daily_volume="504530"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="+0.62"
change_from_200_day_moving_average="3.50"
change_from_50_day_moving_average="1.69"
change_from_52_week_high="-6.42"
change_From_52_week_low="19.63"
change_in_percent="+1.94%"
close="32.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.81"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="32.80"
high_52_weeks="38.92"
last_trade_date="1/3/2017"
last_trade_price="32.50"
last_trade_size="17785"
last_trade_time="4:00pm"
low="31.50"
low_52_weeks="12.87"
market_capitalization="1.69B"
moving_average_200_day="29.00"
moving_average_50_day="30.81"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="32.31"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+12.06%"
percent_change_from_50_day_moving_average="+5.48%"
percent_change_from_52_week_high="-16.49%"
percent_change_from_52_week_low="+152.53%"
previous_close="31.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.15"
price_per_sales="35.35"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="13.10"
stock_exchange="NGM"
symbol="TBPH"
volume="236204"
weeks_range_52="12.87 - 38.92"
